SCHEMBL6906641

SCHEMBL6906641

COCC(=O)c1ccc2ccccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.61
HPGD P15428 6/20 0.60
KDM4E B2RXH2 6/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
ALDH1A1 P00352 5/20 0.57
NPC1 O15118 3/20 0.57
RAB9A P51151 2/20 0.57
MAPT P10636 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 2/20 0.55
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
MEN1 O00255 2/20 0.52
HDAC1 Q13547 2/20 0.49
CASP3 P42574 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HSD17B10 Q99714 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4837029 0.83 KDM4E (0.61) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL11830878 0.81 PTPN1 (0.59) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL9589188 0.81 PTPN1 (0.59) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL9536383 0.80 ALDH1A1 (0.55) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2544352 0.80 PTPN1 (0.54) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL1317943 0.79 SMN1; SMN2 (0.72) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL30623333 0.79 SMN1; SMN2 (0.72) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL28183693 0.79 PTPN1 (0.57) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL7946816 0.79 PTPN1 (0.57) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1
SCHEMBL13674512 0.79 PTPN1 (0.53) PTPN1HPGDKDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021113806-A1 ARYLAMIDES AND METHODS OF USE THEREOF GENZYME CORPORATION (US) 2021-06-10 WO disclosed
WO-2020114150-A1 SYNTHESIS METHOD FOR SYNTHESIZING CARBAMATE USING DIMETHYL SULFOXIDE YLIDE, AMINE AND CARBON DIOXIDE 华南理工大学 2020-06-11 WO disclosed
US-6825296-B2 COORDINATION CATALYSTS THE UNIVERSITY OF HONG KONG (HK) 2004-11-30 US disclosed
US-20030191015-A1 Catalyst component for olefin polymerization UNIVERSITY OF HONG KONG, THE (CN) 2003-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191015-A1 Catalyst component for olefin polymerization CBR1, MSMO1, DUOX1 PTPN1 3168/4885HPGD 1971/4885KDM4E 1916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.